Abstract
Maintaining an appropriate acid–base equilibrium is crucial for human health. A primary influencer of this equilibrium is diet, as foods are metabolized into non-volatile acids or bases. Dietary acid load (DAL) is a measure of the acid load derived from diet, taking into account both the potential renal acid load (PRAL) from food components like protein, potassium, phosphorus, calcium, and magnesium, and the organic acids from foods, which are metabolized to bicarbonate and thus have an alkalinizing effect. Current Western diets are characterized by a high DAL, due to large amounts of animal protein and processed foods. A chronic low-grade metabolic acidosis can occur following a Western diet and is associated with increased morbidity and mortality. Nutritional advice focusing on DAL, rather than macronutrients, is gaining rapid attention as it provides a more holistic approach to managing health. However, current evidence for the role of DAL is mainly associative, and underlying mechanisms are poorly understood. This review focusses on the role of DAL in multiple conditions such as obesity, cardiovascular health, impaired kidney function, and cancer.
Similar content being viewed by others
Introduction
The maintenance of acid–base equilibrium is essential to human health, and any shift in this dynamic towards a more acidic environment has been associated with poorer health outcomes, e.g., cardio-metabolic disease and kidney disease [133]. The primary determinants of acid–base homeostasis include dietary acid and alkali load and the body’s ability to excrete acid, which notably reduces with increasing age and decreasing kidney function [43]. Western diets typically consist of large amounts of animal protein and processed foods, which produce a high dietary acid load (DAL). In comparison, vegetarian/vegan diets with high fruit and vegetable content are often low in acid load and high in potassium bases, which can result in a net alkali load [8, 61]. In recent years, the impact of DAL on health and disease has gained increasing recognition [20, 113, 143, 154]. This narrative review aims to introduce this rapidly developing field, offering a comprehensive overview of its current relationships in health and disease.
What is acid–base status?
Human acid–base equilibrium, largely determined by the concentration of hydrogen ions in blood plasma, is a tightly regulated physiological system that aims to maintain blood pH between 7.35 and 7.45 [121]. Human acid–base balance requires that net endogenous acid production (NEAP) equates to net acid excretion (NAE) [40]. The kidneys and lungs are the primary organs maintaining acid–base balance; the lungs excrete volatile carbon dioxide, while the kidneys excrete non-volatile acids generated by metabolic processes. The amount of non-volatile acid produced by human metabolism is described as endogenous acid production (EAP) [133]. The kidneys also reabsorb filtered bicarbonate (“alkali or base”) to buffer endogenous acid and maintain acid–base balance. DAL primarily determines NEAP, stemming from the production of hydrogen ions upon the intake of protein-rich foods, especially animal proteins that are abundant in phosphorus and sulfur [4, 146]. In comparison, fruits and vegetables are high in citrate, which metabolizes to bicarbonate, reducing the DAL [67].
Another potentially important factor in DAL is the diet’s sodium chloride (NaCl) content [41, 42]. A landmark cross-sectional study performed by Frassetto et al. in 77 healthy individuals consuming a high-DAL diet identified that NaCl is independently associated with low-grade hyperchloremic metabolic acidosis [41]. Moreover, the authors postulated that NaCl can drive roughly 50–100% of the acidosis-producing effect of the DAL. However, it is important to emphasize that these data are based on cross-sectional analyses in healthy individuals, and causality is still warranted.
When the balance of acidogenic and base-producing foods is tipped towards the acidic end, low-grade metabolic acidosis may arise. It is important to distinguish this from “true” metabolic acidosis which is defined as a serum bicarbonate level < 22 mmol/l [76] and is a clinical presentation of an increased acid load and/or a reduction in acid excretion. The kidneys excrete acid as either titratable acid or ammonium via a process known as ammoniagenesis [106]. Ammoniagenesis is a glutamine-dependent process that generates bicarbonate ions and excretes ammonium to maintain acid–base balance following H + (acid) accumulation [119]. When the balance of acidogenic and base-producing foods is tipped towards the acidic end, low-grade metabolic acidosis may arise. It is important to distinguish this from “true” metabolic acidosis which is defined as a serum bicarbonate level < 22 mmol/l [76] and is a clinical presentation of an increased acid load and/or a reduction in acid excretion. The kidneys excrete acid as either titratable acid or ammonium via a process known as ammoniagenesis [106]. Ammoniagenesis is a glutamine-dependent process that generates bicarbonate ions and excretes ammonium to maintain acid–base balance following H + (acid) accumulation [119]. Glutamine is one of several important amino-acids that affect acid–base balance. As discussed previously in this paper, the base- or acid-generating properties of food (especially protein) lie largely in their amino-acid composition. Sulfur-rich amino acids such as cysteine, homocysteine, and methionine, found abundantly in animal protein, are thought to be acid generating as their catabolism produces protons. Plant-based proteins contain amino acids with a net base effect such as: glutamine, glutamate, and glycine [118]. The correlation between DAL and serum amino acids was investigated by Herter et al. [64]. When comparing a meat-rich diet vs a vegan diet, a significant correlation between the DAL and serum concentrations of lysine, glutamine, glycine and 1-methyl-histidine was found. For glutamine, this association was negative, meaning a higher DAL leads to decreasing blood glutamine, therefore requiring more generation. This might have implications for musculoskeletal health, seeing how muscle tissue is one of the main providers of glutamine, which in turn is broken down to handle the acid load.
Continuous exposure to high DAL produces excess ammonium, which causes inflammation and fibrosis via activation of the renin-angiotensin system, complement cascade, and increased production of endothelin-1 [119]. In healthy subjects or individuals with early-stage chronic kidney disease (CKD), increased ammoniagenesis is often accompanied by normal serum bicarbonate levels and is referred to as a sub-clinical, eubicarbonatemic, or normobicarbonatemic acidosis, which has been linked to the development of cardiometabolic disease, CKD progression, and poor muscular-skeletal health [53].
Consequently, a significant amount of research in this field is now focused on identifying clinically relevant biomarkers of eubicarbonatemic acidosis to facilitate early identification and targeted treatment. Potential biomarkers that have shown promise in identifying eubicarbonatemic acidosis include urinary ammonium excretion, urinary citrate, and urine pH [46, 133, 153].
Determining dietary acid load
Precise measurements of NAE or DAL are complex and require evaluation of food consumption, stool, and urine samples. Currently, urinary pH, urinary ammonium, and predictive dietary equations are commonly used methods of assessing DAL. However, more recently, there has been increasing interest in the use of urinary citrate and urinary anion gap as biomarkers of acidosis [46, 151]. However, no gold standard exists to determine DAL, warranting further research.
Dietary acid load and urine pH
At a population level, urine dipstick assessment of random and 24-h urine samples has been shown to reflect DAL in healthy subjects and those with type 2 diabetes [102]. Moreover, void and 24-h urine samples have performed equally well in evaluating urine pH [133]. With additional research needed to quantify ranges, urine pH may provide a simple and cost-effective method of measuring DAL and the success of therapeutic clinical interventions. However, it must be noted that urine pH may not be a reliable measure of DAL in the presence of compromised kidney function or renal tubular acidosis [133]. Therefore, more research is needed in this context using large longitudinal population cohorts in order to verify if urine pH can effectively reflect DAL in subjects with poor renal function.
Dietary acid load and urinary ammonium
In the absence of renal disease, an increase in urinary ammonium reflects an increase in DAL [153]. With respect to CKD, a progressive reduction in renal ammonium excretion is a potential determinant of CKD metabolic acidosis and is independently associated with a decline in kidney function [119]. Urinary ammonium can be measured using void and 24-h urine samples, although there is little evidence regarding how well these correlate with each other[150]. Multiple pre-analytical limitations of using urinary ammonium in clinical practice exist. First is the need for urine-specific assays. However, studies have evaluated plasma ammonium assays on diluted urine samples and demonstrated that this method can reliably quantify urinary ammonium [56, 122]. The dilution of urine samples is necessary due to their high concentration levels. Specifically, the concentration of ammonium in urine is 1000 times higher than that in plasma.
Second is the risk of bacterial contamination, which is a potential source of pre-analytical error when using urinary ammonium as a biomarker [57]. Bacteria capable of degrading urea to ammonium can alter urinary ammonium results, which can have significant implications for clinical practice. The use of void urine samples delivered promptly to the laboratory and freezing samples can negate this issue.
Third is exposure to freeze–thaw cycles; however, a recent study that did not use urine samples from 80 healthy individuals did not identify significant effects of freeze–thaw cycles on the urine metabolome [23]. However, further research is needed to fully understand how freeze–thaw cycles affect urinary ammonium and to determine if any adjustments or corrections are necessary when analyzing samples that have undergone these cycles.
Given the aforementioned pre-analytical limitations, most laboratories still do not routinely measure urinary ammonium concentrations, but rather use the urine anion gap as a surrogate marker [122]. While the pre-analytical challenges are significant, they can be overcome and it is crucial to validate plasma assays for measuring urinary ammonium. This is particularly important as urinary ammonium levels, especially in void samples, could offer a clinical method for detecting and managing acidosis across various disease states. Moreover, direct measurement of urinary ammonium is likely a better marker to assess acid–base status than the often-used urinary anion gap, which serves as a rough surrogate marker [122].
However, further research is necessary to establish how accurately urinary ammonium reflects DAL in patients with eubicarbonatemic acidosis and early-stage CKD.
Urinary anion gap
The urinary anion gap (UAG) is used to express an imbalance between the total cations and anions measured in urine. It is determined by the concentration of sodium, potassium, and chloride ions in urine. UAG is frequently used as a surrogate for urinary ammonium as it is cheaper and easier to measure [151]. Rehman et al. have suggested that UAG is a “rough marker” of urinary ammonium, and its use is limited to the initial evaluation of acidosis [122]. The description of UAG as a “rough marker” relates to concerns regarding the validity of UAG measurements due to potential errors in the original research promoting the use of anion gap, changes in DAL over recent years promoted by the use of food additives, and the need for a steady state renal function to produce accurate results [151]. In addition, there may be a poor agreement between direct urinary ammonium and anion gap measurements [57].
These factors highlight the complexity and limitations of using the urinary anion gap as a reliable marker for assessing DAL.
Dietary acid load and urinary citrate
One promising biomarker for determining acid–base status is urinary citrate, as two recent studies, one randomized control trial (RCT) and the other an observational study, demonstrated an inverse relationship between urinary citrate and acidosis in CKD [46, 52]. Furthermore, these studies have shown that reducing DAL or initiating alkali therapy can increase urinary citrate levels, yet serum bicarbonate remained unchanged. The limitations of these studies are their design: the RCT was comprised of CKD stage 1 and 2 patients with a diagnosis of hypertensive nephropathy and requires further evaluation in other CKD and non-CKD populations. Whereas the observational study comprised solely of kidney stone formers known to have disruptive acid–base metabolism [66]. Nevertheless, these studies provide valuable insights into the relationship between urinary citrate levels and acid–base metabolism. However, it is important to note that the findings may not be applicable to all populations with CKD or those without kidney disease. Further research involving diverse CKD and non-CKD populations is necessary to validate the potential role of urinary citrate as a biomarker for acidosis.
Dietary acid load and predictive equations
Several validated predictive equations are used to estimate the DAL based on measures of dietary intake [101, 124, 133], with NEAPF being the most commonly used [44]. Parmenter et al. [116] have recently evaluated multiple methods of determining the NEAP, NEA, and the potential renal acid load (PRAL), which is the total of acids and bases derived from dietary compounds consisting of cations and anions.
Based on the good agreement between the formulas and their biochemical equivalents, the authors recommended mainly three formulas (NEAPR [123], NEAPL [90], and PRALs [135]) to be used in research perspective on a population level (Table 1). However, the accuracy of these intake-based equations, especially at an individual level, limits their use for clinical practice.
One of the main drawbacks of assessing DAL through food-diary-based equations is imprecision in measuring dietary intake, stemming from inaccurate reporting and fluctuations over time [77]. Moreover, the absorption of nutrients in the gastro-intestinal tract and the actual nutrient composition of specific foods can differ significantly among individuals due to, for example, food preparation methods [35]. Therefore, further research is required to identify biomarkers that reflect variations in nutritional intake and correspond with DAL.
One recently published cross-sectional study investigated several potential biomarkers of covert acid stress in 313 individuals with early-stage (stage G1–G3) CKD [49]. The authors identified 8-h urinary citrate levels to be the best potential biomarker for covert acid stress, specifically in CKD stage G2–G3. However, this was not the case for CKD stage G1. Urinary ammonium levels were best associated with CKD stage G1 but not with more progressive kidney function loss, as the association between CKD stage G2 and G3 diverged. The results of this study further confirm that urinary citrate and ammonium levels can help identify individuals with covert acid stress. However, future intervention studies are needed in order to identify thresholds that can have clinical implications.
Dietary acid load in metabolic disorders
Dietary acid load and obesity
Cardio-metabolic diseases (CMD) represent an umbrella term encompassing, among others, type 2 diabetes, hypertension, and atherosclerosis [111]. Currently, CMD are among the leading cause of morbidity and mortality worldwide [128] and are often accompanied by insulin resistance and obesity (body mass index (BMI) > 30 kg/m.2) [78]. Moreover, metabolic acidosis has recently been proposed as a consequence of obesity [84, 86]. Importantly, many of the foods contributing to obesity are high in calories but are also considered to be acidogenic due to their high content of animal protein and table salt, especially in a typical Western diet. A meta-analysis found that higher DAL was associated with higher levels of triglycerides and obesity incidence, thereby suggesting that reducing DAL may be a novel measure to combat obesity [1].
However, controversy exists about whether a poor diet in an obese population is indeed directly associated with a high DAL and metabolic acidosis. In a recent retrospective study, obese patients with an eGFR > 90 ml/min/1.73m2 had a parallel increase of anion gap acidosis and BMI, indicating that acidosis becomes more prevalent with an increase in body weight. Consequently, there was also an inverse relationship between bicarbonate and BMI [84, 85]. However, a large (n > 100.000) observational cohort study found the exact opposite, i.e., higher BMI is associated with lower incident metabolic acidosis in a CKD population [98]. The authors explained this aberrant finding by hypothesizing that increased bone density, secondary to gravitational stress pushing on bone tissue following obesity, produces more buffering capacity as bone is a reservoir of the base. However, this study was observational by design; thus, causality and underlying pathways remain to be studied.
Moreover, it is important to recognize that a high DAL is associated with muscle catabolism and muscle loss, resulting in sarcopenia and frailty, which can affect BMI measurement. Furthermore, DAL is also associated with metabolic acidosis, which acts as a potent stimulator of protein catabolism by triggering two systems responsible for intracellular protein degradation, caspase-3 and the ubiquitin–proteasome systems (UPS) [14], and by promoting insulin and growth hormone resistance [68].
In addition to BMI, several studies report a positive association between high DAL and various other anthropometric measurements. These include an increased waist-to-height ratio, larger hip and neck circumference, a higher fat mass, and lower fat-free mass [11, 96, 141, 142]. Moreover, a study involving 3018 individuals aged 60 years and older from the USA identified that a high DAL is not only positively correlated with BMI but also with sagittal abdominal diameter [142]. This association was also found in a study in 456 children from Iran, which identified a positive association between a high DAL and a greater risk of childhood obesity, as defined by BMI and higher body fat percentage [141].
Overall, the evidence seems to be in favor of obesity being associated with an increased DAL, and subsequently, DAL may play a role in obesity-driven conditions such as diabetes, hypertension, and CKD.
To date, no study has been performed investigating the effects of specifically targeting DAL in an obese population to lower the risk of obesity-associated metabolic conditions. These studies are urgently needed to disentangle the relationship between DAL and obesity.
Dietary acid load and insulin resistance
Several cohort studies, which excluded subjects with diabetes and other metabolic disorders, have shown an association between a high DAL and insulin resistance [88, 140, 160]. These findings have also been validated in a larger cross-sectional trial where 104 participants provided dietary data spanning several days and serum lactate values during this period [158]. Subsequently, the participants underwent the gold-standard for insulin resistance, hyperinsulinemic-euglycemic clamp, to quantify insulin sensitivity. Results suggest that higher fasting plasma lactate, as an indicator of low-grade metabolic acidosis, correlates positively with insulin resistance, even when subjects were matched for obesity. Obese participants overall had higher plasma lactate when compared to lean subjects with similar insulin sensitivity, and this indicated that obesity on its own causes a rise in lactate and, therefore, might have more background acidosis.
The mechanism of action by which lower extracellular pH affects how cells process insulin is unclear. An in vitro study of rat myoblasts showed that a more acidic environment reduced phosphorylation (activity) of both the insulin receptor as well as downstream insulin signaling receptors [60]. Of note, pH had to be below 7.2 for these effects to become evident. One intriguing hypothesis is that insulin resistance might be a physiological response. By reducing the effectivity of insulin, more muscle protein becomes available for breakdown and conversion to ammonium, which in turn buffers acid [4].
Current evidence strongly favors an association between a high DAL and increased insulin resistance. However, the exact interplay and underlying mechanisms remain unknown. Current Western diets are known to contain a high DAL and promote obesity and insulin resistance [25]. The complex relationship between diet, obesity, and insulin resistance makes it challenging to decipher the contribution of purely a high DAL to the development of insulin resistance.
Dietary acid load and MASLD
Insulin resistance is likely one of the mechanisms that explain the correlation between high DAL and metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease incidence (NAFLD) [125, 152]. Retrospective and prospective studies found correlations between measures of DAL (PRAL and NEAP) and incidence of MASLD [7, 21, 32, 82]. Some find a linear association between increases in DAL and NAFLD incidence, whereas others report a U-shaped association [7, 32]. Fat accumulation in the liver, the hallmark of MASLD, due to chronic metabolic acidosis, can be caused by growth hormone (GH) resistance and hepatic lipid accumulation [36, 110]. The results of the association must be interpreted based on the quality of the data, as most studies consist of retrospective analyses or prospective studies without intervention. Both are at significant risk of biases, and to our knowledge, no studies exist that use alkaline diets vs placebo to test for a reduction in MASLD.
Dietary acid load and cardiovascular mortality
Several large-scale prospective studies have identified an increased risk of all-cause cardiovascular mortality, incident diabetes, hypertension, and kidney disease progression due to metabolic acidosis [15, 94, 95, 115]. In a recent cohort study involving pre-dialysis patients who either received bicarbonate or did not, an analysis was conducted on the occurrence of dialysis and major adverse cardiovascular events (MACE) [24]. The investigators observed that the incorporation of supplementary bicarbonate did not impact the likelihood of initiating dialysis. Nevertheless, individuals utilizing bicarbonate exhibited markedly diminished risks (hazard ratio (HR) 0.92; 95% confidence interval (CI) 0.92–0.98) of major adverse cardiovascular events (MACE) and mortality in comparison to those who did not use bicarbonate (HR 0.75; 95% CI 0.74–0.77).
Not only metabolic acidosis but also a high DAL has been associated with increased (cardiovascular) morbidity and mortality in multiple observational cohorts [2, 6, 38, 130].
Abbasalizad Farhangi et al. reported an increased 10-year mortality risk in 454 individuals who underwent coronary artery bypass grafting (CABG) surgery (HR 1.023; 95% CI 1.00–1.04) [2]. Fereidouni et al. evaluated multiple dietary scores (Mediterranean dietary score, Alternative Healthy Eating Index score, DASH score, Dietary Inflammatory Index score, and dietary acid load) with regard to mortality risk in 2158 cardiovascular disease (CVD) patients. The authors concluded, based on a limited 3-year follow-up, that only the Dietary Inflammatory Index score (HR 1.11; 95% CI 1.01–1.24 and dietary acid load (HR 1.02; 95% CI 1.01–1.03) were significantly associated with increased mortality in CVD patients [38]).
One prospective study by Xu et al. [159] had an additional interesting result that the association between DAL and cardiovascular mortality seems to be U-shaped, which was supported by results from another study [62]. This finding suggests that a very high alkali/very low acid diet can also be detrimental to vascular health and mortality. However, two things must be pointed out: (1) the associative nature of these studies makes it impossible to infer causality, and interventional studies are needed to elucidate this finding, and (2) the very low acid content relates to an impaired protein intake, which can influence mortality, and is therefore not a true reflection of a low DAL diet [87].
Dietary acid load and hypertension
Multiple observational studies and a recent systematic review have shown that high DAL may promote hypertension [5, 81, 117, 163]. However, causal evidence is lacking, and randomized controlled trials are warranted. One large observational study (n = 87,293 women) showed that higher DAL is independently associated with an increased risk of incident hypertension [163]. Furthermore, in support of the association of DAL with hypertension, another study demonstrated an inverse relationship between urinary citrate and prevalent hypertension [145]. This is an important finding as urinary citrate is a candidate biomarker for acidosis and can potentially be used as a diagnostic tool for identifying individuals at risk for developing hypertension.
The association between high DAL, increased systolic blood pressure (SBP), and hypertension prevalence was also noted in two other studies where models were adjusted for relevant confounders such as age, sex, BMI, estimated sodium intake, kidney function, and medication use [5, 81].
In support of these findings, a systematic review and meta-analysis of 14 studies (3 prospective and 11 cross-sectional studies, with 306,183 individuals and 62,264 cases of hypertension) identified a significant positive association between DAL and hypertension [117]. However, it is important to note that this meta-analysis was performed on observational data, and interventional studies are warranted to confirm causality.
However, not all observational data demonstrates a positive association between DAL and hypertension. For instance, authors from “The Rotterdam Study,” a prospective cohort study (n = 2241 participants aged > 55 years), provided no evidence of an association between DAL and the risk of hypertension in older adults [33]. Interestingly, the authors noted that the diets of the study population were relatively alkaline and potentially not a true representation of Western populations. Consequently, further research is needed to determine the generalizability of these findings to broader populations with different dietary patterns.
In support of these findings, another observational study also did not identify a relationship between DAL and SBP [83]. However, calculated DAL values were lower than expected and may relate to the use of a 24-h dietary recall to quantify DAL. While 24-h recall is widely used in the clinical setting due to ease of application, it often underestimates dietary intake and does not account for day-to-day dietary variation, which confers bias in the research setting [70].
One small RCT (n = 71) demonstrated a significant reduction in diastolic blood pressure (DBP) but not SBP compared to controls in subjects with type 2 diabetes following a low DAL diet for 12 weeks [10]. Interestingly, this study did not adjust for sodium intake, which has an independent effect on DAL and SBP [41, 55]. Moreover, the authors did not measure compliance adequately in this study. Nevertheless, this study is among the first clinical trials that investigated the role of DAL in hypertension.
The mechanisms by which a high DAL can promote hypertension are poorly understood but may be due to an increase in cortisol and activation of the renin-angiotensin system, which results in vasoconstriction [63, 99]. Increased cortisol levels have also been associated with kidney function decline in subjects with essential hypertension [92]. Additionally, high cortisol levels have been reported to increase profibrotic gene expression in human renal mesangial cells, thereby contributing to further kidney function decline [3].
Moreover, decreased kidney function is also a consequence of a high DAL and can independently increase the risk of hypertension [18].
Dietary acid load and chronic kidney disease
CKD is a major cause of morbidity and mortality worldwide, with increasing prevalence [79]. CKD is defined as a structural or functional kidney function impairment for three or more months. It is generally progressive and irreversible, affecting multiple metabolic pathways, including acid–base derangements resulting in metabolic acidosis [73]. Metabolic acidosis, in turn, can lead to muscle wasting, development or exacerbation of bone disease, hypoalbuminemia, increased inflammation, progression of CKD, alterations in insulin, leptin, and growth hormone, and increased mortality [80, 154].
Diet is a major determinant of the acid load that the kidney must excrete to maintain acid–base balance [48]. It therefore stands to reason that targeting DAL may play a role in preventing CKD.
Indeed, multiple observational studies, as well as systematic reviews, have determined a role for DAL in the treatment and prevention of CKD [104, 139]. Mofrad et al. performed a systematic review and meta-analysis of observational studies on DAL, kidney function, and risk of CKD. They included 23 studies, including 200,092 patients [104]. The meta-analysis, based on nine observational studies, showed that DAL had a positive significant association with the risk of CKD (odds ratio 1.31; 95% CI 1.06, 1.62). Moreover, DAL had a negative association with urine pH (odds ratio − 0.47; 95% confidence interval (CI): − 0.85, − 0.08). Silva et al. performed a systematic review of the relationship between DAL, albuminuria, and eGFR in non-dialysis-dependent CKD patients [139]. The authors included five observational studies four of which found a negative association between DAL and kidney function. In addition, Navaneethan et al. performed a systematic review and meta-analysis to evaluate the benefits and risks of metabolic acidosis treatment with oral alkali supplementation or a reduction of dietary acid intake in patients with CKD [108]. Fourteen clinical trials were included (n = 1394 participants). Treatment of metabolic acidosis with oral alkali supplementation or a reduction of dietary acid intake increased serum bicarbonate levels resulted in a slower decline in eGFR and a reduction in urinary albumin excretion, along with a reduction in the risk of progression to kidney failure.
Currently, the KDOQI clinical practice guideline for nutrition in CKD suggests reducing DAL in adults with CKD through increased dietary intake of fruits and vegetables in order to reduce the rate of decline of residual kidney function [69]. The guideline summarizes three studies showing that higher quartiles of DAL were indeed significantly associated with greater GFR decline [134] and that higher DAL is associated with CKD progression [74]. Moreover, comparing the lowest tertile of DAL with the highest tertile resulted in a greater relative hazard of kidney failure [16].
The association between DAL and kidney function is often attributed to a low intake of fruits and vegetables [147]. Toba et al. showed that low fruit (adjusted odds ratio, 6.45; 95% CI, 2.19–19.00) and vegetable (adjusted OR, 3.87; 95% CI, 1.29–11.6;) intake was indeed associated with high NEAP [147]. Furthermore, a study by Kabasawa et al. showed that potassium is an important dietary component in the association between DAL and albuminuria [72]. These findings are in line with the results of studies by Goraya et al. [50, 51]. The authors found that providing fruits and vegetables to reduce DAL among individuals with hypertensive CKD can lead to reductions in markers of kidney injury, such as a reduction in urinary albumin excretion, without inducing hyperkalemia.
Importantly, a high DAL has been associated with an increase in kidney stone formation [17, 58], potentially due to decreased urine pH and lower citrate levels [17, 149]. This is noteworthy, as kidney stone formation is a well-described risk factor for CKD [129].
Moreover, a recently published retrospective cohort study in 142,884 individuals with CKD stage 3–5 also identified metabolic acidosis as an independent risk factor for kidney stone formation. In fact, a one mmol/L decrease in serum bicarbonate was associated with a 3% increased hazard of developing kidney stones [144]. These findings further highlight the potential to reduce kidney stone formation and lower CKD risk by targeting DAL.
In addition to the relationship between DAL and kidney function decline, another adverse effect of a high dietary acid load in patients with CKD is that it can also result in bone loss and muscle mass loss [133]. Scialla et al. [133] provided an informative schematic presentation of the proposed physiological adaptations and consequences of high dietary acid load in CKD, including bone and muscle loss. Moreover, a systematic review and meta-analysis by Visser et al. showed that correcting metabolic acidosis with alkali therapy significantly improves muscle mass and physical function [155]. Importantly, nutritional interventions may also correct metabolic acidosis. Goraya et al. showed that increased intake of fruits and vegetables yielded better overall health outcomes than did oral sodium bicarbonate [50].
In conclusion, current evidence suggests that DAL is associated with albuminuria and progressive kidney disease, and therefore, DAL should be incorporated into the nutritional advice of patients with CKD. Mechanistically speaking, a high DAL could affect the kidney by toxic effects of elevated ammonium concentrations, potentially through complement activation and direct toxic effect on glomerular cells [27, 54], and invoke adaptive mechanisms to increase acid excretion, such as activation of the renin-angiotensin system and endothelin-1 [16, 133]. However, it is important to recognize that the majority of data is based on observational studies, and intervention studies are needed to further shed light on these relationships.
DAL and bone density
Upon ingesting an acid load, the body must maintain electroneutrality by counterbalancing the surge of positively charged particles. This is achieved either through the excretion of protons (H +) or by buffering with negatively charged particles such as HCO3−. Due to its abundant reserves of alkali calcium salts, bone tissue serves as a pivotal buffer against acid loads, responding even more rapidly than the kidney’s proton excretion mechanism [89].
As DAL is typically high in Western Diets, it has been hypothesized that this continuous acid stress will reduce bone mass.
A decrease in bone mass carries significant implications, notably an elevated risk of fractures. This is particularly important for the elderly population, who often have decreased kidney function, limiting their ability to excrete acid, thereby perpetuating a vicious cycle [39, 75, 93, 109]. However, current studies exploring the link between DAL and bone density present inconsistent findings and are often based on low-quality designs.
One prospective cohort study with 4672 healthy Dutch individuals aged 45 years and older found a significant inverse correlation between NEAP and trabecular bone score (TBS) [28]. TBS is a novel method to assess the microarchitecture of bone and supporting structures; when TBS is combined with bone mineral density (BMD), it provides a good predictor of osteoporotic fractures [59]. The authors also identified a clear distinction based on protein source. Proteins of animal origin had a negative (acid-like) effect on TBS, similar to NEAP, but plant-based protein had a positive effect on TBS. Plant-based protein has less acidogenic properties compared to animal protein due to the fact that plant protein has less sulfur, methionine, and cysteine, which generate H+ [97, 157]. The effects of animal- vs plant-based protein on BMD have been investigated before and summarized in a meta-analysis [137]. The authors did not find strong evidence of whether plant-based protein is truly advantageous over animal-based protein for bone mass, as current studies are mainly observational in design, and only limited small-scale clinical trials were included. The authors concluded that large, long-term RCTs and prospective cohorts are needed to shed more light on this pressing matter.
As mentioned above the association between increased DAL and lower BMD is not always found, a good example of an association study that did not find this relation is the study by McLean et al. [100]. This association study used the Framingham Osteoporosis study but excluded all participants that had a calcium intake > 800 mg/day. The authors found an inverse relation between DAL and femoral neck BMD in older males but not in lumbar spine BMD. For females, there was no association between DAL and BMD.
Another landmark study investigated whether neutralizing a high DAL by providing potassium citrate or a placebo for 2 years to 200 healthy elderly patients improved BMD [71]. The authors concluded that BMD at the lumbar spine increased by 1.7% after 2 years, compared to a placebo. Moreover, the N-amino-terminal telopeptide of type I collagen (NTX), a marker for bone resorption, was reduced only at 6 months. However, the marker for bone formation, PINP, was increased at 18 and 24 months. This implies that the reduction of bone resorption might be a temporary effect, and K-citrate induces a bone formation phenotype in the long term. A similar study provided potassium bicarbonate to healthy post-menopausal women and saw a positive calcium and phosphorus balance [136]. In this study, the authors also noted a shift in markers from bone loss to bone formation.
In summary, current evidence does not inconclusively support the notion that high DAL indeed decreases BMD. However, if this is indeed the case, alkaline potassium salts may offer the potential to counteract this effect. Further RCTs and longitudinal cohort studies are needed to further unravel the relationship between DAL and BMD and whether potassium salts are indeed a good therapy to mitigate this effect.
Dietary acid load and cancer
Multiple observational studies and systematic reviews have established a role for diet in cancer risk and mortality [22, 37, 132]. One recent large-scale prospective cohort study in 197,426 individuals from the UK-biobank identified an increased risk of overall cancer incidence in individuals adhering to a high ultra-processed food diet [22]. In fact, every 10% increment of adherence to an ultra-processed food diet increased overall cancer incidence by 2% and overall mortality by 6%. Moreover, mortality risk was highest in breast and ovarian cancer (16 and 30%, respectively, with every 10% increment increase).
A meta-analysis of prospective observational studies showed an increased risk of breast, colon, rectal, and lung cancer following a high intake of red meat [37]. However, this was not confirmed in a meta-analysis of randomized clinical trials due to the heterogeneity of the interventions and low-quality level evidence [162].
As diets high in (red) meat and ultra-processed food are also often high in DAL [45, 133], it is tempting to hypothesize a relationship between DAL and cancer. However, to date, intervention studies are lacking in investigating this relationship. Two recently published meta-analyses of observational studies did find an increased risk of DAL with cancer incidence and mortality [13, 156]. All the studies included in these meta-analyses derived DAL from either food-frequency questionnaires or diet history questionnaires. In the study of Wang et al. the authors included ten observational studies, of which seven were cohort studies and three were case control. The meta-analyses identified that a high DAL was associated with a 58% increase in risk of developing cancer and also a poor prognosis. The main cancer types included in the meta-analyses were breast, bladder, lung, and glioma. In the study of Brahimi et al. nine studies were included, which largely overlapped with the study of Wang et al. The meta-analyses performed had similar results and found an increase in overall cancer risk of 58–77% due to adherence to a high DAL diet.
Another recently published case–control study from Korea compared 923 cases of colorectal cancer to 1846 controls. DAL was determined via PRAL, NEAP, and NEA from previously validated food-frequency questionnaires, and the authors identified that a high DAL was associated with increased risks in colorectal cancer (odds ratio (OR) of 2.31, with a 95% CI of 1.79–2.99). Notably, this risk was more pronounced for women and was higher for rectal cancer compared to colon cancer [148].
The increased risk of cancer following a high DAL was also confirmed in another large-scale case–control cohort from Uruguay [127]. In this study, the authors summarize the results of their previous work, which encompassed a total of 3736 cancer cases and 9534 controls in a 12-year timeframe. This study describes multiple cancer-types, including breast, lung, colorectal, and oro-pharynx-larynx cancer. DAL was determined via NEAP and PRAL which were derived from food-frequency questionnaires. The authors concluded that a high DAL was associated with an increased risk of cancer, in all cancer sites, with the exception being kidney and oral cavity cancer. Interestingly, the authors also performed a sub-analysis and identified a significantly higher methionine intake in all cases of cancer compared to their controls, and also higher in women compared to men. This is of note as methionine is a sulfur-containing essential amino acid found abundantly in meat, with important metabolic effects [31]. The authors suggest that reducing extreme methionine intake can potentially lower the risk of cancer development due to a high DAL, but more research is needed in this regard.
Nevertheless, it is crucial to emphasize that the current level of evidence regarding the relationship between DAL and cancer risk and mortality is predominantly based on observational data, often of poor quality, which limits the capacity to infer causality [65]. Intervention studies are urgently needed in order to gain more insight into this relationship and better understand the mechanisms behind it.
Mechanistically speaking, the relationship between DAL and cancer is complex and likely to result in multiple metabolic alterations, as summarized by Ronco et al. [127].
As discussed previously, a high DAL has been associated with increased insulin resistance which is suggested to be a driving force behind cancer development, especially in combination with increased (low-grade) inflammation and production of reactive oxygen species (ROS) [9, 107]. These effects can further be augmented by an increase in insulin-like growth factor-1 (IGF-1), following a high-protein diet, which is often also high in DAL [91].
Moreover, chronic exposure to a high DAL can induce a low-grade metabolic acidosis which can promote tumorgenesis via several mechanisms. These include increased cortisol production and direct toxic effects on cells, promoting genomic instability and tumor invasion [34, 47, 126].
DAL and cognitive function
Beyond the somatic effects linked to an elevated DAL, it is important to also consider potential cognitive and mental health implications. This is underscored by multiple observational studies that have found an association between increased DAL and heightened levels of anxiety and depression [103, 105, 131]. One of the largest studies, performed in 4378 adult individuals from Iran, identified that a high DAL was associated with an increased risk of both depression (OR 2.0; 95% CI 1.52; 2.64) as well as anxiety (OR 1.92; 95% CI 1.35; 2.74). However, the current understanding of the relationship between DAL and cognitive function is derived from observational data, which does not rule out potential confounding factors and cannot establish causality.
Mechanistically speaking, a high DAL has been associated with increased levels of cortisol, which in turn can increase the risk of depressive disorders [120, 161]. Cortisol levels have been proposed as a potential biomarker for mental disorder severity in general [30]. However, it is important to note that mechanistic studies directly investigating the effects of DAL on cognitive functions are currently lacking.
Future perspectives
Dietary acid load (DAL) is rapidly gaining recognition as a nutritional concept that can affect a myriad of conditions, such as insulin resistance, cardiovascular health, kidney disease, and risk of cancer [112, 114, 133].
From a population perspective, the importance of DAL is notable given that contemporary Western diets, characterized by a high intake of processed foods, animal protein, and salt, predominantly result in elevated DAL [26]. While the body can effectively buffer transient elevations in DAL, chronic exposure may lead to (low-grade) metabolic acidosis. Such a state is recognized to elevate the risk of cardiometabolic diseases and cancer, thereby significantly affecting morbidity and mortality [29, 126]. The relationship between a high DAL and its consequences is summarized in Fig. 1.
In order to lower DAL, dietary patterns rich in plant-based proteins, fruits, vegetables, and nuts are advisable. Examples of such dietary patterns are DASH and the Mediterranean diet. The DAL of commonly used food groups and patterns are summarized in Table 2.
It is important to note that current evidence for the relationship between a high DAL and its health consequences is mainly based on observational studies. Therefore, causality is often unclear in the described relationships. Moreover, the role of the gut microbiota, which is crucial in the interaction between diet and host metabolism, is understudied [12]. Currently, only two ongoing clinical trials that focus on the role of DAL in CKD are registered (Table 3). However, to elucidate the relationship between an elevated DAL and its (metabolic) consequences, longitudinal cohort and dietary intervention studies are warranted across various domains of non-communicable diseases. Understanding this relationship will provide a more holistic approach to nutritional recommendations.
Data availability
Upon reasonable request from the corresponding author.
Abbreviations
- BMD:
-
Bone mineral density
- BMI:
-
Body mass index
- CKD:
-
Chronic kidney disease
- CMD:
-
Cardio metabolic diseases
- DAL:
-
Dietary acid load
- DBP:
-
Diastolic blood pressure
- EAP:
-
Endogenous acid production
- MACE:
-
Major adverse cardiovascular events
- NAE:
-
Net acid excretion
- NEAP:
-
Net endogenous acid production
- NTX:
-
N-amino-terminal telopeptide of type I collagen
- PRAL:
-
Potential renal acid load
- SBP:
-
Systolic blood pressure
- TBS:
-
Trabecular bone score
- UAG:
-
Urinary anion gap
References
Abbasalizad Farhangi M, Nikniaz L, Nikniaz Z (2019) Higher dietary acid load potentially increases serum triglyceride and obesity prevalence in adults: an updated systematic review and meta-analysis. PLoS ONE 14:e0216547. https://doi.org/10.1371/journal.pone.0216547
Abbasalizad Farhangi M, Vajdi M, Najafi M (2019) Dietary acid load significantly predicts 10-years survival in patients underwent coronary artery bypass grafting (CABG) surgery. PLoS ONE 14:e0223830. https://doi.org/10.1371/journal.pone.0223830
Ackermann D, Vogt B, Bochud M, Burnier M, Martin P-Y, Paccaud F, Ehret G, Guessous I, Ponte B, Pruijm M, Pechère-Bertschi A, Jamin H, Klossner R, Dick B, Mohaupt MG, Gennari-Moser C (2022) Increased glucocorticoid metabolism in diabetic kidney disease. PLoS ONE 17:e0269920. https://doi.org/10.1371/journal.pone.0269920
Adeva MM, Souto G (2011) Diet-induced metabolic acidosis. Clin Nutr 30:416–421. https://doi.org/10.1016/j.clnu.2011.03.008
Akter S, Eguchi M, Kurotani K, Kochi T, Pham NM, Ito R, Kuwahara K, Tsuruoka H, Mizoue T, Kabe I, Nanri A (2015) High dietary acid load is associated with increased prevalence of hypertension: the Furukawa Nutrition and Health Study. Nutrition 31:298–303. https://doi.org/10.1016/j.nut.2014.07.007
Akter S, Nanri A, Mizoue T, Noda M, Sawada N, Sasazuki S, Tsugane S, Japan Public Health Center-based Prospective Study Group (2017) Dietary acid load and mortality among Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr 106:146–154. https://doi.org/10.3945/ajcn.117.152876
Alferink LJM, Kiefte-de Jong JC, Erler NS, de Knegt RJ, Hoorn EJ, Ikram MA, Janssen HLA, Metselaar HJ, Franco OH, Darwish Murad S (2019) Diet-dependent acid load-the missing link between an animal protein-rich diet and nonalcoholic fatty liver disease? J Clin Endocrinol Metab 104:6325–6337. https://doi.org/10.1210/jc.2018-02792
Angeloco LRN, Arces de Souza GC, Romão EA, Frassetto L, Chiarello PG (2020) Association of dietary acid load with serum bicarbonate in chronic kidney disease (CKD) patients. Eur J Clin Nutr 74:69–75. https://doi.org/10.1038/s41430-020-0689-1
Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A (2012) Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012:789174. https://doi.org/10.1155/2012/789174
Armin M, Heidari Z, Askari G, Iraj B, Clark CCT, Rouhani MH (2023) The effect of a low renal acid load diet on blood pressure, lipid profile, and blood glucose indices in patients with type 2 diabetes: a randomized clinical trial. Nutr J 22:18. https://doi.org/10.1186/s12937-023-00849-6
Aslani Z, Bahreynian M, Namazi N, Shivappa N, Hébert JR, Asayesh H, Motlagh ME, Pourmirzaei MA, Kasaeian A, Mahdavi-Gorabi A, Qorbani M, Kelishadi R (2021) Association of dietary acid load with anthropometric indices in children and adolescents. Eat Weight Disord 26:555–567. https://doi.org/10.1007/s40519-020-00883-x
Attaye I, Pinto-Sietsma S-J, Herrema H, Nieuwdorp M (2020) A crucial role for diet in the relationship between gut microbiota and cardiometabolic disease. Annu Rev Med 71:149–161. https://doi.org/10.1146/annurev-med-062218-023720
Bahrami A, Khalesi S, Ghafouri-Taleghani F, Alibeyk S, Hajigholam-Saryazdi M, Haghighi S, Hejazi E (2022) Dietary acid load and the risk of cancer: a systematic review and dose-response meta-analysis of observational studies. Eur J Cancer Prev 31:577–584. https://doi.org/10.1097/CEJ.0000000000000748
Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE (1996) The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97:1447–1453. https://doi.org/10.1172/jci118566
Banerjee T, Crews DC, Wesson DE, Tilea A, Saran R, Rios Burrows N, Williams DE, Powe NR, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team (2014) Dietary acid load and chronic kidney disease among adults in the United States. BMC Nephrol 15:137. https://doi.org/10.1186/1471-2369-15-137
Banerjee T, Crews DC, Wesson DE, Tilea AM, Saran R, Ríos-Burrows N, Williams DE, Powe NR, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team (2015) High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol 26:1693–1700. https://doi.org/10.1681/ASN.2014040332
Betz MV, Penniston KL (2023) Primary contributors to dietary acid load in patients with urolithiasis. J Ren Nutr 33:53–58. https://doi.org/10.1053/j.jrn.2022.05.005
Bidani AK, Griffin KA (2004) Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44:595–601. https://doi.org/10.1161/01.HYP.0000145180.38707.84
Bio-Practica (2018) The-PRAL-Table.pdf. https://inaturally.com.au/wp-content/uploads/2020/04/The-PRAL-Table.pdf. Accessed 12 Jan 2023
Carnauba RA, Baptistella AB, Paschoal V, Hübscher GH (2017) Diet-induced low-grade metabolic acidosis and clinical outcomes: a review. Nutrients 25;9(6):538. https://doi.org/10.3390/nu9060538
Chan R, Wong VW-S, Chu WC-W, Wong GL-H, Li LS, Leung J, Chim AM-L, Yeung DK-W, Sea MM-M, Woo J, Chan FK-L, Chan HL-Y (2015) Higher estimated net endogenous acid production may be associated with increased prevalence of nonalcoholic fatty liver disease in chinese adults in Hong Kong. PLoS ONE 10:e0122406. https://doi.org/10.1371/journal.pone.0122406
Chang K, Gunter MJ, Rauber F, Levy RB, Huybrechts I, Kliemann N, Millett C, Vamos EP (2023) Ultra-processed food consumption, cancer risk and cancer mortality: a large-scale prospective analysis within the UK Biobank. EClinicalMedicine 56:101840. https://doi.org/10.1016/j.eclinm.2023.101840
Chen D, Chan W, Zhao S, Li L, Li L (2022) High-coverage quantitative metabolomics of human urine: effects of freeze-thaw cycles on the urine metabolome and biomarker discovery. Anal Chem 94:9880–9887. https://doi.org/10.1021/acs.analchem.2c01816
Cheng Y-L, Huang S-C, Ho M-Y, Li Y-R, Yen C-L, Chen K-H, Sun W-C, Fan P-Y, Chen J-S, Lin C, Hsiao C-C (2023) Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease. Front Pharmacol 14:1146668. https://doi.org/10.3389/fphar.2023.1146668
Clemente-Suárez VJ, Beltrán-Velasco AI, Redondo-Flórez L, Martín-Rodríguez A, Tornero-Aguilera JF (2023) Global impacts of Western diet and its effects on metabolism and health: a narrative review. Nutrients 15(12):2749. https://doi.org/10.3390/nu15122749
Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O’Keefe JH, Brand-Miller J (2005) Origins and evolution of the Western diet: health implications for the 21st century1,2. Am J Clin Nutr 81:341–354. https://doi.org/10.1093/ajcn.81.2.341
Dasarathy S, Mookerjee RP, Rackayova V, Rangroo Thrane V, Vairappan B, Ott P, Rose CF (2017) Ammonia toxicity: from head to toe? Metab Brain Dis 32:529–538. https://doi.org/10.1007/s11011-016-9938-3
de Jonge EAL, Koromani F, Hofman A, Uitterlinden AG, Franco OH, Rivadeneira F, Kiefte-de Jong JC (2017) Dietary acid load, trabecular bone integrity, and mineral density in an ageing population: the Rotterdam Study. Osteoporos Int 28:2357–2365. https://doi.org/10.1007/s00198-017-4037-9
DiNicolantonio JJ, O’Keefe J (2021) Low-grade metabolic acidosis as a driver of chronic disease: a 21st century public health crisis. Open Heart 8:e001730. https://doi.org/10.1136/openhrt-2021-001730
Dziurkowska E, Wesolowski M (2021) Cortisol as a biomarker of mental disorder severity. J Clin Med 10:5204. https://doi.org/10.3390/jcm10215204
Elango R (2020) Methionine nutrition and metabolism: insights from animal studies to inform human nutrition. J Nutr 150:2518S-2523S. https://doi.org/10.1093/jn/nxaa155
Emamat H, Farhadnejad H, Poustchi H, Teymoori F, Bahrami A, Hekmatdoost A (2022) The association between dietary acid load and odds of non-alcoholic fatty liver disease: a case-control study. Nutr Health 2601060221088383. https://doi.org/10.1177/02601060221088383
Engberink MF, Bakker SJL, Brink EJ, van Baak MA, van Rooij FJA, Hofman A, Witteman JCM, Geleijnse JM (2012) Dietary acid load and risk of hypertension: the Rotterdam Study. Am J Clin Nutr 95:1438–1444. https://doi.org/10.3945/ajcn.111.022343
Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73:1524–1535. https://doi.org/10.1158/0008-5472.CAN-12-2796
Fabbri ADT, Crosby GA (2016) A review of the impact of preparation and cooking on the nutritional quality of vegetables and legumes. Int J Gastron Food Sci 3:2–11. https://doi.org/10.1016/j.ijgfs.2015.11.001
Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M, Sperling MA (2009) Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem 284:19937–19944. https://doi.org/10.1074/jbc.M109.014308
Farvid MS, Sidahmed E, Spence ND, Mante Angua K, Rosner BA, Barnett JB (2021) Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol 36:937–951. https://doi.org/10.1007/s10654-021-00741-9
Fereidouni S, Hejazi N, Homayounfar R, Farjam M (2023) Diet quality and dietary acid load in relation to cardiovascular disease mortality: results from Fasa PERSIAN cohort study. Food Sci Nutr 11:1563–1571. https://doi.org/10.1002/fsn3.3197
Frassetto L, Banerjee T, Powe N, Sebastian A (2018) Acid balance, dietary acid load, and bone effects-a controversial subject. Nutrients 10. https://doi.org/10.3390/nu10040517
Frassetto L, Remer T, Banerjee T (2022) Dietary contributions to metabolic acidosis. Adv Chronic Kidney Dis 29:373–380. https://doi.org/10.1053/j.ackd.2022.03.008
Frassetto LA, Morris RC Jr, Sebastian A (2007) Dietary sodium chloride intake independently predicts the degree of hyperchloremic metabolic acidosis in healthy humans consuming a net acid-producing diet. Am J Physiol Renal Physiol 293:F521–F525. https://doi.org/10.1152/ajprenal.00048.2007
Frassetto LA, Morris RC Jr, Sellmeyer DE, Sebastian A (2008) Adverse effects of sodium chloride on bone in the aging human population resulting from habitual consumption of typical American diets. J Nutr 138:419S-422S. https://doi.org/10.1093/jn/138.2.419S
Frassetto LA, Sebastian A, DuBose TD Jr (2020) How metabolic acidosis and kidney disease may accelerate the aging process. Eur J Clin Nutr 74:27–32. https://doi.org/10.1038/s41430-020-0693-5
Frassetto LA, Todd KM, Morris RC Jr, Sebastian A (1998) Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr 68:576–583. https://doi.org/10.1093/ajcn/68.3.576
Gannon RHT, Millward DJ, Brown JE, Macdonald HM, Lovell DP, Frassetto LA, Remer T, Lanham-New SA (2008) Estimates of daily net endogenous acid production in the elderly UK population: analysis of the National Diet and Nutrition Survey (NDNS) of British adults aged 65 years and over. Br J Nutr 100:615–623. https://doi.org/10.1017/S0007114508901240
Gianella FG, Prado VE, Poindexter JR, Adams-Huet B, Li X, Miller RT, Sakhaee K, Maalouf NM, Moe OW (2021) Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease. Kidney Int 99:208–217. https://doi.org/10.1016/j.kint.2020.07.006
Gillies RJ, Verduzco D, Gatenby RA (2012) Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 12:487–493. https://doi.org/10.1038/nrc3298
Gonick HC, Goldberg G, Mulcare D (1968) Reexamination of the acid-ash content of several diets. Am J Clin Nutr 21:898–903. https://doi.org/10.1093/ajcn/21.9.898
Goraya N, Madias NE, Mamun A, Simoni J, Wesson DE (2022) Biomarkers of covert acid stress in patients with chronic kidney disease: a cross-sectional study. Am J Nephrol 53:794–805. https://doi.org/10.1159/000529112
Goraya N, Munoz-Maldonado Y, Simoni J, Wesson DE (2021) Treatment of chronic kidney disease-related metabolic acidosis with fruits and vegetables compared to NaHCO3 yields more and better overall health outcomes and at comparable five-year cost. J Ren Nutr 31:239–247. https://doi.org/10.1053/j.jrn.2020.08.001
Goraya N, Simoni J, Jo C-H, Wesson DE (2014) Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int 86:1031–1038. https://doi.org/10.1038/ki.2014.83
Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE (2019) Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis. Kidney Int 95:1190–1196. https://doi.org/10.1016/j.kint.2018.11.033
Goraya N, Wesson DE (2017) Management of the metabolic acidosis of chronic kidney disease. Adv Chronic Kidney Dis 24:298–304. https://doi.org/10.1053/j.ackd.2017.06.006
Gordon DL, Krueger RA, Quie PG, Hostetter MK (1985) Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator. J Immunol 134:3339–3345. https://doi.org/10.4049/jimmunol.134.5.3339
Grillo S, Coruzzi S, Parati G (2019) Sodium intake and hypertension. Nutrients 11:1970. https://doi.org/10.3390/nu11091970
Gruzdys V, Cahoon K, Pearson L, Raphael KL (2022) Measurement of urinary ammonium using a commercially available plasma ammonium assay. Kidney360 3:926–932. https://doi.org/10.34067/KID.0000262022
Ha LY, Chiu WW, Davidson JS (2012) Direct urine ammonium measurement: time to discard urine anion and osmolar gaps. Ann Clin Biochem 49:606–608. https://doi.org/10.1258/acb.2012.012013
Haghighatdoost F, Sadeghian R, Clark CCT, Abbasi B (2021) Higher dietary acid load is associated with an increased risk of calcium oxalate kidney stones. J Ren Nutr 31:467–474. https://doi.org/10.1053/j.jrn.2020.08.012
Hans D, Goertzen AL, Krieg M-A, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762–2769. https://doi.org/10.1002/jbmr.499
Hayata H, Miyazaki H, Niisato N, Yokoyama N, Marunaka Y (2014) Lowered extracellular pH is involved in the pathogenesis of skeletal muscle insulin resistance. Biochem Biophys Res Commun 445:170–174. https://doi.org/10.1016/j.bbrc.2014.01.162
He L-Q, Wu X-H, Huang Y-Q, Zhang X-Y, Shu L (2021) Dietary patterns and chronic kidney disease risk: a systematic review and updated meta-analysis of observational studies. Nutr J 20:4. https://doi.org/10.1186/s12937-020-00661-6
Hejazi E, Emamat H, Sharafkhah M, Saidpour A, Poustchi H, Sepanlou S, Sotoudeh M, Dawsey S, Boffetta P, Abnet CC, Kamangar F, Etemadi A, Pourshams A, Malekshah AF, Berennan P, Malekzadeh R, Hekmatdoost A (2022) Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study. Br J Nutr 128:237–243. https://doi.org/10.1017/S0007114521003135
Henger A, Tutt P, Riesen WF, Hulter HN, Krapf R (2000) Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. J Lab Clin Med 136:379–389. https://doi.org/10.1067/mlc.2000.110371
Herter J, Lederer A-K, Ronco AL, Hannibal L, Huber R, Storz MA (2023) Dietary acid load correlates with serum amino acid concentrations after a four-week intervention with vegan vs. Meat-rich diets: a secondary data analysis. Nutrients 15. https://doi.org/10.3390/nu15132942
Hess AS, Abd-Elsayed A (2019) Observational studies: uses and limitations. Pain. Springer International Publishing, Cham, pp 123–125
Hess B (2006) Acid-base metabolism: implications for kidney stones formation. Urol Res 34:134–138. https://doi.org/10.1007/s00240-005-0026-0
Ho JQ, Abramowitz MK (2022) Clinical consequences of metabolic acidosis-muscle. Adv Chronic Kidney Dis 29:395–405. https://doi.org/10.1053/j.ackd.2022.04.010
Hu Z, Wang H, Lee IH, Du J, Mitch WE (2009) Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest. https://doi.org/10.1172/jci38770
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L (2020) KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 76:S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006
Jackson KA, Byrne NM, Magarey AM, Hills AP (2008) Minimizing random error in dietary intakes assessed by 24-h recall, in overweight and obese adults. Eur J Clin Nutr 62:537–543. https://doi.org/10.1038/sj.ejcn.1602740
Jehle S, Hulter HN, Krapf R (2013) Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 98:207–217. https://doi.org/10.1210/jc.2012-3099
Kabasawa K, Hosojima M, Takachi R, Nakamura K, Ito Y, Saito A, Sawada N, Tsugane S, Tanaka J, Narita I (2019) Association of estimated dietary acid load with albuminuria in Japanese adults: a cross-sectional study. BMC Nephrol 20:194. https://doi.org/10.1186/s12882-019-1352-8
Kalantar-Zadeh K, Fouque D (2017) Nutritional management of chronic kidney disease. N Engl J Med 377:1765–1776. https://doi.org/10.1056/NEJMra1700312
Kanda E, Ai M, Kuriyama R, Yoshida M, Shiigai T (2014) Dietary acid intake and kidney disease progression in the elderly. Am J Nephrol 39:145–152. https://doi.org/10.1159/000358262
Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936. https://doi.org/10.1016/S0140-6736(02)08761-5
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1–S276. https://doi.org/10.1016/j.kint.2021.05.021
Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ (2002) Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr 5:915–923. https://doi.org/10.1079/PHN2002383
Kirk EP, Klein S (2009) Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens 11:761–765. https://doi.org/10.1111/j.1559-4572.2009.00054.x
Kovesdy CP (2011) (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12:7–11. https://doi.org/10.1016/j.kisu.2021.11.003
Kraut JA, Madias NE (2017) Adverse effects of the metabolic acidosis of chronic kidney disease. Adv Chronic Kidney Dis 24:289–297. https://doi.org/10.1053/j.ackd.2017.06.005
Krupp D, Esche J, Mensink GBM, Klenow S, Thamm M (2018) Remer T (2018) Dietary acid load and potassium intake associate with blood pressure and hypertension prevalence in a representative sample of the German adult population. Nutrients 10(1):103. https://doi.org/10.3390/nu10010103
Krupp D, Johner SA, Kalhoff H, Buyken AE, Remer T (2012) Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women. J Nutr 142:313–319. https://doi.org/10.3945/jn.111.150540
Kucharska AM, Szostak-Węgierek DE, Waśkiewicz A, Piotrowski W, Stepaniak U, Pająk A, Kozakiewicz K, Tykarski A, Rutkowski M, Bielecki WJ, Drygas W (2018) Dietary acid load and cardiometabolic risk in the Polish adult population. Adv Clin Exp Med 27:1347–1354. https://doi.org/10.17219/acem/69733
Lambert DC, Abramowitz MK (2021) Obesity, anion accumulation, and anion gap metabolic acidosis: a cohort study. Kidney360 2:1706–1715. https://doi.org/10.34067/KID.0003562021
Lambert DC, Abramowitz MK (2021) Obesity and the risk of low bicarbonate: a cohort study. Kidney Med 3:498-506.e1. https://doi.org/10.1016/j.xkme.2021.02.006
Lambert DC, Kane J, Slaton A, Abramowitz MK (2022) Associations of metabolic syndrome and abdominal obesity with anion gap metabolic acidosis among US adults. Kidney360 3:1842–1851. https://doi.org/10.34067/KID.0002402022
Langsetmo L, Harrison S, Jonnalagadda S, Pereira SL, Shikany JM, Farsijani S, Lane NE, Cauley JA, Stone K, Cawthon PM (2020) Low protein intake irrespective of source is associated with higher mortality among older community-dwelling men. J Nutr Health Aging 24:900–905. https://doi.org/10.1007/s12603-020-1422-4
Lee KW, Shin D (2020) Positive association between dietary acid load and future insulin resistance risk: findings from the Korean Genome and Epidemiology Study. Nutr J 19:137. https://doi.org/10.1186/s12937-020-00653-6
Lemann J Jr, Bushinsky DA, Hamm LL (2003) Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 285:F811–F832. https://doi.org/10.1152/ajprenal.00115.2003
Lennon EJ, Lemann J Jr (1968) Influence of diet composition on endogenous fixed acid production. Am J Clin Nutr 21:451–456. https://doi.org/10.1093/ajcn/21.5.451
Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng C-W, Madia F, Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, Passarino G, Kennedy BK, Wei M, Cohen P, Crimmins EM, Longo VD (2014) Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab 19:407–417. https://doi.org/10.1016/j.cmet.2014.02.006
Li X, Xiang X, Hu J, Goswami R, Yang S, Zhang A, Wang Y, Li Q, Bi X (2016) Association between serum cortisol and chronic kidney disease in patients with essential hypertension. Kidney Blood Press Res 41:384–391. https://doi.org/10.1159/000443435
Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO (2014) Chronic kidney disease in the elderly: evaluation and management. Clin Pract 11:525–535. https://doi.org/10.2217/cpr.14.46
Mandel EI, Curhan GC, Hu FB, Taylor EN (2012) Plasma bicarbonate and risk of type 2 diabetes mellitus. CMAJ 184:E719–E725. https://doi.org/10.1503/cmaj.120438
Mandel EI, Forman JP, Curhan GC, Taylor EN (2013) Plasma bicarbonate and odds of incident hypertension. Am J Hypertens 26:1405–1412. https://doi.org/10.1093/ajh/hpt133
Mansordehghan M, Daneshzad E, Basirat V, Gargari BP, Rouzitalab T (2022) The association between dietary acid load and body composition in physical education students aged 18–25 years. J Health Popul Nutr 41:58. https://doi.org/10.1186/s41043-022-00340-8
Massey LK (2003) Dietary animal and plant protein and human bone health: a whole foods approach. J Nutr 133:862S-865S. https://doi.org/10.1093/jn/133.3.862S
Mathur V, Reaven NL, Funk SE, Ferguson TW, Tangri N (2023) Association of body mass index with the development of metabolic acidosis in patients with chronic kidney disease. Obes Sci Pract. https://doi.org/10.1002/osp4.672
Maurer M, Riesen W, Muser J, Hulter HN, Krapf R (2003) Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol 284:F32-40. https://doi.org/10.1152/ajprenal.00212.2002
McLean RR, Qiao N, Broe KE, Tucker KL, Casey V, Cupples LA, Kiel DP, Hannan MT (2011) Dietary acid load is not associated with lower bone mineral density except in older men. J Nutr 141:588–594. https://doi.org/10.3945/jn.110.135806
Michaud DS, Troiano RP, Subar AF, Runswick S, Bingham S, Kipnis V, Schatzkin A (2003) Comparison of estimated renal net acid excretion from dietary intake and body size with urine pH. J Am Diet Assoc 103:1001–7. https://doi.org/10.1016/s0002-8223(03)00469-3
Miki A, Hashimoto Y, Tanaka M, Kobayashi Y, Wada S, Kuwahata M, Kido Y, Yamazaki M, Fukui M (2017) Urinary pH reflects dietary acid load in patients with type 2 diabetes. J Clin Biochem Nutr 61:74–77. https://doi.org/10.3164/jcbn.16-118
Milajerdi A, Hassanzadeh Keshteli A, Haghighatdoost F, Azadbakht L, Esmaillzadeh A, Adibi P (2020) Dietary acid load in relation to depression and anxiety in adults. J Hum Nutr Diet 33:48–55. https://doi.org/10.1111/jhn.12658
Mofrad MD, Daneshzad E, Azadbakht L (2021) Dietary acid load, kidney function and risk of chronic kidney disease: a systematic review and meta-analysis of observational studies. Int J Vitam Nutr Res 91:343–355. https://doi.org/10.1024/0300-9831/a000584
Mozaffari H, Siassi F, Guilani B, Askari M, Azadbakht L (2020) Association of dietary acid-base load and psychological disorders among Iranian women: a cross-sectional study. Complement Ther Med 53:102503. https://doi.org/10.1016/j.ctim.2020.102503
Nagami GT, Hamm LL (2017) Regulation of acid-base balance in chronic kidney disease. Adv Chronic Kidney Dis 24:274–279. https://doi.org/10.1053/j.ackd.2017.07.004
Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112:3945–3952. https://doi.org/10.1111/cas.15068
Navaneethan SD, Shao J, Buysse J, Bushinsky DA (2019) Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol 14:1011–1020. https://doi.org/10.2215/CJN.13091118
Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721–731. https://doi.org/10.1038/ki.2008.264
Ordóñez FA, Santos F, Martínez V, García E, Fernández P, Rodríguez J, Fernández M, Alvarez J, Ferrando S (2000) Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatr Nephrol 14:720–725. https://doi.org/10.1007/pl00013425
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA (2018) Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 17, Article number: 122. https://doi.org/10.1186/s12933-018-0762-4
Ostrowska J, Janiszewska J, Szostak-Węgierek D (2020) Dietary acid load and cardiometabolic risk factors-a narrative review. Nutrients 12:3419. https://doi.org/10.3390/nu12113419
Osuna-Padilla IA, Leal-Escobar G, Garza-García CA, Rodríguez-Castellanos FE (2019) Carga ácida de la dieta; mecanismos y evidencia de sus repercusiones en la salud. Nefrol (Engl Ed) 39:343–354. https://doi.org/10.1016/j.nefro.2018.10.005
Osuna-Padilla IA, Leal-Escobar G, Garza-García CA, Rodríguez-Castellanos FE (2019) Dietary acid load: mechanisms and evidence of its health repercussions. Nefrol (Engl Ed) 39:343–354. https://doi.org/10.1016/j.nefroe.2019.08.001
Park M, Jung SJ, Yoon S, Yun JM, Yoon H-J (2015) Association between the markers of metabolic acid load and higher all-cause and cardiovascular mortality in a general population with preserved renal function. Hypertens Res 38:433–438. https://doi.org/10.1038/hr.2015.23
Parmenter BH, Dymock M, Banerjee T, Sebastian A, Slater GJ, Frassetto LA (2020) Performance of predictive equations and biochemical measures quantifying net endogenous acid production and the potential renal acid load. Kidney Int Rep 5:1738–1745. https://doi.org/10.1016/j.ekir.2020.07.026
Parohan M, Sadeghi A, Nasiri M, Maleki V, Khodadost M, Pirouzi A, Sadeghi O (2019) Dietary acid load and risk of hypertension: a systematic review and dose-response meta-analysis of observational studies. Nutr Metab Cardiovasc Dis 29:665–675. https://doi.org/10.1016/j.numecd.2019.03.009
Passey C (2017) Reducing the dietary acid load: how a more alkaline diet benefits patients with chronic kidney disease. J Ren Nutr 27:151–160. https://doi.org/10.1053/j.jrn.2016.11.006
Pourafshar N, Pourafshar S, Soleimani M (2018) Urine ammonium, metabolic acidosis and progression of chronic kidney disease. Nephron 138:222–228. https://doi.org/10.1159/000481892
Qin D-D, Rizak J, Feng X-L, Yang S-C, Lü L-B, Pan L, Yin Y, Hu X-T (2016) Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour. Sci Rep 6, Article number: 30187. https://doi.org/10.1038/srep30187
Rajkumar P, Pluznick JL (2018) Acid-base regulation in the renal proximal tubules: using novel pH sensors to maintain homeostasis. Am J Physiol Renal Physiol 315:F1187–F1190. https://doi.org/10.1152/ajprenal.00185.2018
Rehman MZ, Melamed M, Harris A, Shankar M, Rosa RM, Batlle D (2023) Urinary ammonium in clinical medicine: direct measurement and the urine anion gap as a surrogate marker during metabolic acidosis. Adv Kidney Dis Health 30:197–206. https://doi.org/10.1053/j.akdh.2022.12.006
Remer T, Manz F (1994) Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr 59:1356–1361. https://doi.org/10.1093/ajcn/59.6.1356
Remer T, Manz F (1995) Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95:791–797. https://doi.org/10.1016/S0002-8223(95)00219-7
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW-S, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79(6):1542–1556 https://doi.org/10.1016/j.jhep.2023.06.003
Robey IF (2012) Examining the relationship between diet-induced acidosis and cancer. Nutr Metab (Lond) 9:72. https://doi.org/10.1186/1743-7075-9-72
Ronco AL, Storz MA (2023) Dietary acid load and cancer risk: a review of the Uruguayan experience. Nutrients 15(14):3098. https://doi.org/10.3390/nu15143098
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol 76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Rule AD, Bergstralh EJ, Melton LJ, Li X, Weaver AL, Lieske JC (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804–811. https://doi.org/10.2215/cjn.05811108
Sanz JM, Sergi D, Colombari S, Capatti E, Situlin R, Biolo G, Di Girolamo FG, Lazzer S, Šimunič B, Pišot R, Passaro A (2022) Dietary acid load but not Mediterranean diet adherence score is associated with metabolic and cardiovascular health state: a population observational study from northern Italy. Front Nutr 9:828587. https://doi.org/10.3389/fnut.2022.828587
Saul A, Taylor BV, Blizzard L, Simpson-Yap S, Probst YC, Black LJ, Ponsonby AL, Broadley SA, Lechner Scott J, van der Mei I (2023) Long-term dietary acid load is associated with depression in multiple sclerosis, but less evidence was found with fatigue and anxiety. Mult Scler Relat Disord 69:104415. https://doi.org/10.1016/j.msard.2022.104415
Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L (2016) Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev 74:737–748. https://doi.org/10.1093/nutrit/nuw045
Scialla JJ, Anderson CAM (2013) Dietary acid load: a novel nutritional target in chronic kidney disease? Adv Chronic Kidney Dis 20:141–149. https://doi.org/10.1053/j.ackd.2012.11.001
Scialla JJ, Appel LJ, Astor BC, Miller ER III, Beddhu S, Woodward M, Parekh RS, Anderson CAM (2012) Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int 82:106–112. https://doi.org/10.1038/ki.2012.82
Sebastian A, Frassetto LA, Sellmeyer DE, Merriam RL, Morris RC Jr (2002) Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Am J Clin Nutr 76:1308–1316. https://doi.org/10.1093/ajcn/76.6.1308
Sebastian A, Morris RC Jr (1994) Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 331:279
Shams-White MM, Chung M, Fu Z, Insogna KL, Karlsen MC, LeBoff MS, Shapses SA, Sackey J, Shi J, Wallace TC, Weaver CM (2018) Animal versus plant protein and adult bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. PLoS ONE 13:e0192459. https://doi.org/10.1371/journal.pone.0192459
Siener R (2018) Dietary treatment of metabolic acidosis in chronic kidney disease. Nutrients 10:512. https://doi.org/10.3390/nu10040512
Silva L, Moço SA, Antunes ML, Ferreira AS, Moreira AC (2021) Dietary acid load and relationship with albuminuria and glomerular filtration rate in individuals with chronic kidney disease at predialysis state. Nutrients 14:170. https://doi.org/10.3390/nu14010170
Smeha L, Fassula AS, Franco Moreno YM, Gonzalez-Chica DA, Nunes EA (2022) Dietary acid load is positively associated with insulin resistance: a population-based study. Clin Nutr ESPEN 49:341–347. https://doi.org/10.1016/j.clnesp.2022.03.025
Sorraya N, Arab A, Talebi S (2022) The association between dietary acid load and adiposity measures among children and adolescents. BMC Pediatr 22:484. https://doi.org/10.1186/s12887-022-03541-6
Storz MA, Ronco AL (2023) Dietary acid load decreases with age and is associated with sagittal abdominal diameter: a nationally representative quantification study in US adults. Aging Clin Exp Res 35:2191–2200. https://doi.org/10.1007/s40520-023-02508-6
Storz MA, Ronco AL, Hannibal L (2022) Observational and clinical evidence that plant-based nutrition reduces dietary acid load. J Nutr Sci 11:e93. https://doi.org/10.1017/jns.2022.93
Tangri N, Mathur V, Reaven NL, Funk SE, Whitlock RH, Wesson DE, Bushinsky DA (2023) Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study. Clin Kidney J 16:1113–1121. https://doi.org/10.1093/ckj/sfad034
Taylor EN, Mount DB, Forman JP, Curhan GC (2006) Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780–789. https://doi.org/10.1053/j.ajkd.2006.01.024
Thorpe MP, Evans EM (2011) Dietary protein and bone health: harmonizing conflicting theories. Nutr Rev 69:215–230. https://doi.org/10.1111/j.1753-4887.2011.00379.x
Toba K, Hosojima M, Kabasawa H, Kuwahara S, Murayama T, Yamamoto-Kabasawa K, Kaseda R, Wada E, Watanabe R, Tanabe N, Suzuki Y, Narita I, Saito A (2019) Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease. BMC Nephrol 20:421. https://doi.org/10.1186/s12882-019-1591-8
Tran TT, Gunathilake M, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J (2023) The association of diet-dependent acid load with colorectal cancer risk: a case-control study in Korea. Br J Nutr 131(2):333–342. https://doi.org/10.1017/S0007114523001691
Trinchieri A, Lizzano R, Marchesotti F, Zanetti G (2006) Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers. Urol Res 34:1–7. https://doi.org/10.1007/s00240-005-0001-9
Uribarri J, Goldfarb DS, Raphael KL, Rein JL, Asplin JR (2022) Beyond the urine anion gap: in support of the direct measurement of urinary ammonium. Am J Kidney Dis 80:667–676. https://doi.org/10.1053/j.ajkd.2022.05.009
Uribarri J, Oh MS (2021) The urine anion gap: common misconceptions. J Am Soc Nephrol 32:1025–1028. https://doi.org/10.1681/ASN.2020101509
Utzschneider KM, Kahn SE (2006) The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753–4761. https://doi.org/10.1210/jc.2006-0587
Vallet M, Metzger M, Haymann J-P, Flamant M, Gauci C, Thervet E, Boffa J-J, Vrtovsnik F, Froissart M, Stengel B, Houillier P, NephroTest Cohort Study group (2015) Urinary ammonia and long-term outcomes in chronic kidney disease. Kidney Int 88:137–145. https://doi.org/10.1038/ki.2015.52
Vincent-Johnson A, Davy B, Scialla JJ (2023) Diet and metabolism in CKD-related metabolic acidosis. Semin Nephrol 43:151425. https://doi.org/10.1016/j.semnephrol.2023.151425
Visser WJ, van de Braak EEM, de Mik-van Egmond AME, van der Burgh AC, de Roos NM, Jans I, van der Hoef I, Olieman JF, Hoorn EJ, Severs D (2023) Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.13330
Wang R, Wen Z-Y, Liu F-H, Wei Y-F, Xu H-L, Sun M-L, Zhao Y-H, Gong T-T, Wang H-H, Wu Q-J (2022) Association between dietary acid load and cancer risk and prognosis: an updated systematic review and meta-analysis of observational studies. Front Nutr 9:891936. https://doi.org/10.3389/fnut.2022.891936
Wesson DE (2021) The continuum of acid stress. Clin J Am Soc Nephrol 16:1292–1299. https://doi.org/10.2215/CJN.17541120
Williams RS, Heilbronn LK, Chen DL, Coster ACF, Greenfield JR, Samocha-Bonet D (2016) Dietary acid load, metabolic acidosis and insulin resistance - lessons from cross-sectional and overfeeding studies in humans. Clin Nutr 35:1084–1090. https://doi.org/10.1016/j.clnu.2015.08.002
Xu H, Åkesson A, Orsini N, Håkansson N, Wolk A, Carrero JJ (2016) Modest U-shaped association between dietary acid load and risk of all-cause and cardiovascular mortality in adults. J Nutr 146:1580–1585. https://doi.org/10.3945/jn.116.231019
Xu H, Jia T, Huang X, Risérus U, Cederholm T, Arnlöv J, Sjögren P, Lindholm B, Carrero J-J (2014) Dietary acid load, insulin sensitivity and risk of type 2 diabetes in community-dwelling older men. Diabetologia 57:1561–1568. https://doi.org/10.1007/s00125-014-3275-z
Zajkowska Z, Gullett N, Walsh A, Zonca V, Pedersen GA, Souza L, Kieling C, Fisher HL, Kohrt BA, Mondelli V (2022) Cortisol and development of depression in adolescence and young adulthood - a systematic review and meta-analysis. Psychoneuroendocrinology 136:105625. https://doi.org/10.1016/j.psyneuen.2021.105625
Zeraatkar D, Johnston BC, Bartoszko J, Cheung K, Bala MM, Valli C, Rabassa M, Sit D, Milio K, Sadeghirad B, Agarwal A, Zea AM, Lee Y, Han MA, Vernooij RWM, Alonso-Coello P, Guyatt GH, El Dib R (2019) Effect of lower versus higher red meat intake on cardiometabolic and cancer outcomes: a systematic review of randomized trials. Ann Intern Med 171:721–731. https://doi.org/10.7326/M19-0622
Zhang L, Curhan GC, Forman JP (2009) Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension 54:751–755. https://doi.org/10.1161/HYPERTENSIONAHA.109.135582
Acknowledgements
Figures created via https://app.biorender.com/.
Funding
IA was funded through an ACS post-doctoral grant (2022); BBC was funded by a CRN West Midlands Personal Development Award and the Center for Care Excellence at UHCW NHS Trust.
Author information
Authors and Affiliations
Contributions
M.L.A.J.W, B.B.C, W.J.V and I.A conceptualized the project and wrote the review.
M.L.A.J.W created the figure and tables. All authors read and approved the final version of the manuscript.
MLAJW, BBC, WJV, and IA conceptualized the project and wrote the review. MLAJW created the figure and tables. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the special issue on Physiology of systemic and cellular pH regulation in Pflügers Archiv—European Journal of Physiology.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wieërs, M.L.A.J., Beynon-Cobb, B., Visser, W.J. et al. Dietary acid load in health and disease. Pflugers Arch - Eur J Physiol 476, 427–443 (2024). https://doi.org/10.1007/s00424-024-02910-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-024-02910-7